Cargando…

Redefined clinical spectra of diabetic foot syndrome

PURPOSE: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. PATIENTS AND METHODS: This is a retrospective study of type 2 diabetic patients referred with DFS for management at K...

Descripción completa

Detalles Bibliográficos
Autores principales: Shatnawi, Nawaf J, Al-Zoubi, Nabil A, Hawamdeh, Hasan, Khader, Yousef S, Omari, Abd El-Karim, Khammash, Muhammad R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201996/
https://www.ncbi.nlm.nih.gov/pubmed/30425505
http://dx.doi.org/10.2147/VHRM.S169502
_version_ 1783365617869389824
author Shatnawi, Nawaf J
Al-Zoubi, Nabil A
Hawamdeh, Hasan
Khader, Yousef S
Omari, Abd El-Karim
Khammash, Muhammad R
author_facet Shatnawi, Nawaf J
Al-Zoubi, Nabil A
Hawamdeh, Hasan
Khader, Yousef S
Omari, Abd El-Karim
Khammash, Muhammad R
author_sort Shatnawi, Nawaf J
collection PubMed
description PURPOSE: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. PATIENTS AND METHODS: This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. RESULTS: In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. CONCLUSION: Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results.
format Online
Article
Text
id pubmed-6201996
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62019962018-11-13 Redefined clinical spectra of diabetic foot syndrome Shatnawi, Nawaf J Al-Zoubi, Nabil A Hawamdeh, Hasan Khader, Yousef S Omari, Abd El-Karim Khammash, Muhammad R Vasc Health Risk Manag Original Research PURPOSE: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. PATIENTS AND METHODS: This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. RESULTS: In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. CONCLUSION: Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. Dove Medical Press 2018-10-18 /pmc/articles/PMC6201996/ /pubmed/30425505 http://dx.doi.org/10.2147/VHRM.S169502 Text en © 2018 Shatnawi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Shatnawi, Nawaf J
Al-Zoubi, Nabil A
Hawamdeh, Hasan
Khader, Yousef S
Omari, Abd El-Karim
Khammash, Muhammad R
Redefined clinical spectra of diabetic foot syndrome
title Redefined clinical spectra of diabetic foot syndrome
title_full Redefined clinical spectra of diabetic foot syndrome
title_fullStr Redefined clinical spectra of diabetic foot syndrome
title_full_unstemmed Redefined clinical spectra of diabetic foot syndrome
title_short Redefined clinical spectra of diabetic foot syndrome
title_sort redefined clinical spectra of diabetic foot syndrome
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201996/
https://www.ncbi.nlm.nih.gov/pubmed/30425505
http://dx.doi.org/10.2147/VHRM.S169502
work_keys_str_mv AT shatnawinawafj redefinedclinicalspectraofdiabeticfootsyndrome
AT alzoubinabila redefinedclinicalspectraofdiabeticfootsyndrome
AT hawamdehhasan redefinedclinicalspectraofdiabeticfootsyndrome
AT khaderyousefs redefinedclinicalspectraofdiabeticfootsyndrome
AT omariabdelkarim redefinedclinicalspectraofdiabeticfootsyndrome
AT khammashmuhammadr redefinedclinicalspectraofdiabeticfootsyndrome